Hospital
Mercy Hospital, Iowa City, Iowa
Mercy Hospital, Iowa City, Iowa was paid $6.37M by Medicaid between Jan 2018 and Jan 2024, across 89 billing codes. Its largest line is 99284, emergency room visit (serious) — 41% of everything it billed.
33Billing provider infoMERCY HOSPITAL, IOWA CITY, IOWA
IOWA CITY, IA 52245
IOWA CITY, IA 52245
33aNPI1982664124assigned 03/23/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.37M
24GClaims110,054
24DCodes billed89
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other General Acute Care Hospital providers in Iowa
Rank by total paid#15 of 29
Median peer was paid$6.37M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,958 | $1.00M | |
| 2019 | 22,836 | $1.12M | |
| 2020 | 13,693 | $778K | |
| 2021 | 18,834 | $1.11M | |
| 2022 | 21,243 | $1.30M | |
| 2023 | 16,998 | $1.04M | |
| 2024incomplete | 492 | $35K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 41% | 12,036 | 11,061 | $2.59M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 14,546 | 13,569 | $2.00M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9.2% | 5,639 | 5,115 | $589K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 3,067 | 2,935 | $240K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 357 | 292 | $146K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.7% | 1,725 | 1,123 | $110K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 1,453 | 1,323 | $89K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 2,849 | 2,426 | $89K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 469 | 386 | $84K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.3% | 299 | 271 | $82K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 375 | 129 | $59K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 566 | 528 | $53K |
77 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,546 | $50K |
| 59025 | Fetal non-stress test | <1% | 343 | $47K |
| 71045 | Radiologic examination, chest; single view | <1% | 243 | $15K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 121 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 297 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 14,604 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 340 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 175 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 325 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,287 | $7K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 65 | $7K |
| 0002A | <1% | 184 | $6K | |
| 0001A | <1% | 194 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 364 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 54 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,688 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 17 | $2K |
| 80061 | Lipid panel | <1% | 182 | $2K |
| 0012A | <1% | 73 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 74 | $2K |
| 0011A | <1% | 71 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 112 | $925.02 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 26 | $840.59 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,043 | $621.93 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 27 | $605.86 |
| 85027 | <1% | 90 | $508.82 | |
| 87081 | <1% | 68 | $471.09 | |
| 87340 | <1% | 26 | $245.89 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $233.06 |
| 81001 | <1% | 2,364 | $217.80 | |
| 84703 | <1% | 2,420 | $216.04 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 26 | $191.10 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 639 | $164.79 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 24 | $161.46 |
| 86592 | <1% | 27 | $106.72 | |
| 94761 | <1% | 17 | $35.67 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 498 | $12.01 |
| 83690 | <1% | 2,192 | $6.89 | |
| 84484 | <1% | 1,373 | $4.38 | |
| 86140 | <1% | 814 | $3.77 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,564 | $2.36 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,248 | $1.44 |
| 82150 | 0% | 12 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 2,388 | $0.00 |
| 91301 | 0% | 150 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 41 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 125 | $0.00 |
| 86901 | 0% | 31 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 235 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 29 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 256 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 38 | $0.00 |
| 83605 | 0% | 85 | $0.00 | |
| 83735 | 0% | 293 | $0.00 | |
| 96376 | 0% | 76 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 15 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 39 | $0.00 |
| 85379 | 0% | 28 | $0.00 | |
| 86850 | 0% | 13 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 15 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 2,698 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 457 | $0.00 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 531 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 191 | $0.00 |
| 87631 | 0% | 14 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 881 | $0.00 |
| 87634 | 0% | 100 | $0.00 | |
| 73562 | 0% | 13 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 62 | $0.00 |
| 84702 | 0% | 89 | $0.00 | |
| 81003 | 0% | 182 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 131 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 96 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 78 | $0.00 |
| 73610 | 0% | 32 | $0.00 | |
| 73630 | 0% | 16 | $0.00 | |
| 91300 | 0% | 376 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOGS, MICHELE (EXECUTIVE ASSISTANT)
| Provider | Location | Paid |
|---|---|---|
| Mercy Services Iowa City, INC. | Iowa City, IA | $2.44M |
| Mercy Hospital, Iowa City, Iowa | Iowa City, IA | $588K |
| Mercy Hospital, Iowa City, Iowa | Iowa City, IA | $470K |
| Mercy Services Iowa City, INC. | West Liberty, IA | $302K |
| Mercy Services Iowa City, INC. | Iowa City, IA | $295K |
| Mercy Services Iowa City, INC. | Tipton, IA | $232K |
| Mercy Services Iowa City, INC. | West Branch, IA | $90K |
| Mercy Services Iowa City, INC. | Kalona, IA | $58K |
| Mercy Services Iowa City, INC. | Solon, IA | $640.48 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.